ARMYDA-ACS (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Acute Coronary Syndromes ) trial: Multicenter randomized, placebo-controlled, double blind, prospective trial evaluating the improved outcomes of atorvastatin pre-treatment load in patients with acute coronary syndromes undergoing early PCI / Germano Di, Sciascio; Giuseppe, Patti; Vincenzo, Pasceri; Giuseppe, Colonna; Sardella, Gennaro; Marco, Miglionico; Luigi, Fischetti; Andrea, D’Ambrosio; Giordano, Dicuonzo; Nguyen, BICH LIEN; Antonio, Montinaro; Annunziata, Nusca. - (2007).
ARMYDA-ACS (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Acute Coronary Syndromes ) trial: Multicenter randomized, placebo-controlled, double blind, prospective trial evaluating the improved outcomes of atorvastatin pre-treatment load in patients with acute coronary syndromes undergoing early PCI
SARDELLA, Gennaro;NGUYEN, BICH LIEN;
2007
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
